Nykode Therapeutics ASA is a clinical-stage biotech company based in Norway that designs vaccines and immunotherapies. Its modular technology platform delivers antigens to the immune system to trigger targeted responses, and the company applies it to therapeutic cancer vaccines and preventive vaccines against infectious diseases. It works with partners and collaborators on development programmes, and its pipeline spans candidates for various cancers and infections.
Nykode Therapeutics ASA trades under the code NYKD on the Oslo Børs in Norway, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #167 of 294 on the Oslo Børs · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Norway yet.
TrendWeak
49/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-5.6%
From 52-week high-37.3%
MomentumFair
60/100
Typical recent returns for this exchange.
See the numbers →
3-month return-2.6%
6-month return-0.2%
12-month, skipping last month71.4%
Stability (higher is calmer)Weak
25/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)79.1%
Worst drawdown, 1 year (smaller is calmer)-37.4%
LiquidityStrong
70/100
Trades actively.
See the numbers →
Avg daily value traded9.14M NOK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends1
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Norway when fundamentals data for this market is added. All Norway stocks.
52-wk range 2.058 – 5.200Daily closes, split-adjusted
Signals
50-day average3.808
200-day average3.314
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.153
Technical summary
Daily
Strongly bearish
0 bullish · 4 neutral · 12 bearish
Weekly
Strongly bearish
2 bullish · 1 neutral · 9 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
3.17
Bearish
EMA 10
3.21
Bearish
SMA 20
3.32
Bearish
EMA 20
3.33
Bearish
SMA 50
3.81
Bearish
EMA 50
3.51
Bearish
SMA 100
3.47
Bearish
EMA 100
3.47
Bearish
SMA 200
3.31
Bearish
EMA 200
3.27
Bearish
Oscillators (daily)
RSI (14)
35.72
Neutral
MACD (12, 26)
-0.16
Bearish
Momentum (12)
-9.01
Bearish
Stochastic %K (14)
22.55
Neutral
Williams %R (14)
-77.45
Neutral
CCI (20)
-84.56
Neutral
Pivot points (classic, last session)
S3
3.05
S2
3.08
S1
3.10
Pivot
3.13
R1
3.15
R2
3.18
R3
3.20
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 NOK
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
1.0000
Ex-dividend dates and amounts from our market-data provider. Shown as declared, before tax.
Prices are end-of-day closes in NOK. Educational only, not financial advice.
